ArticleRSC advances2019

Discovery of a novel phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor against hematologic malignancies and theoretical studies on its PI3Kγ-specific binding mechanisms.

Jingyu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.